Asanidze E, Kristesashvili J, Andguladze S
1I. Javakhishvili Tbilisi State University; Center for Reproductive Medicine "Universe".
2Medical Corporation "Evex", Tbilisi, Georgia.
Georgian Med News. 2019 May(290):25-29.
There are controversial opinions regarding the impact of hyperhomocysteinemia (HHcy) and insulin resistance in PCOS patients who experience Recurrent Pregnancy Loss (RPL). Nowadays the correlation between levels of anti-müllerian hormone (AMH), homocysteine and insulin resistance (IR) have become the main subject of interest in PCOS patients for predicting RPL. Objective - investigate the relationship between level of homocysteine, anti-müllerian hormone and insulin resistance in PCOS patients with Recurrent Pregnancy Loss. 80 Georgian young women (<30 years) with PCOS were involved in the prospective study. The diagnosis of PCOS was based on the criteria of Rotterdam Consensus 2003. Patients were divided into two groups: group I-50 patients, who experienced RPL, and group II-30 patients with live births in anamnesis (control group). Patients with RPL were divided into two subgroups: subgroup A-with insulin resistance (n=28), and subgroup B-without insulin resistance (n=22). All patients underwent hormonal investigation from day 2 to 3 of menstrual cycle. Plasma levels of anti-müllerian hormone, homocysteine, follicle-stimulating hormone, luteinizing hormone (LH), total testosterone (T), free testosterone (FT), sex hormone binding globulin (SHBG) were determined. Between 2-3 days of the menstrual cycle all participants underwent an ultrasound examination using Voluson E10. This was done to determine ovarian volume and antral follicle count. Average homocysteine (Hcy) level in PCOS patients with RPL (11.5±2.24μmol/l) was significantly higher than in controls (7.55±2.45 μmol/l, p<0.001). Incidence of (HHcy) and IR in patients with RPL was 70% and 56% respectively, which was significantly higher than in controls (HHcy-54.3%; IR- 9.4%; p<0.0001). HOMA-IR in patients with RPL was significantly higher compared with controls (p<0.001). Average AMH level in patients with RPL and live births did not differ significantly. In the group of PCOS with RPL significant positive correlation between Hcy and HOMA-IR, BMI, AMH and FT levels was found (p<0.001). Serum homocysteine level is elevated in PCOS patients with RPL. This elevation is correlated with the degree of obesity, BMI, Insulin Resistance status, AMH and androgen levels. The treatment of hyperhomocysteinemia and insulin resistance in women with PCOS might become the bases for prevention of pregnancy losses and improving reproductive outcomes.
对于高同型半胱氨酸血症(HHcy)和胰岛素抵抗对经历复发性流产(RPL)的多囊卵巢综合征(PCOS)患者的影响,存在有争议的观点。如今,抗苗勒管激素(AMH)水平、同型半胱氨酸与胰岛素抵抗(IR)之间的相关性已成为PCOS患者预测RPL的主要研究兴趣点。目的——研究复发性流产的PCOS患者中同型半胱氨酸水平、抗苗勒管激素与胰岛素抵抗之间的关系。80名格鲁吉亚年轻女性(<30岁)的PCOS患者参与了这项前瞻性研究。PCOS的诊断基于2003年鹿特丹共识标准。患者被分为两组:第一组——50名经历过RPL的患者,第二组——30名有活产史的患者(对照组)。有RPL的患者被分为两个亚组:亚组A——有胰岛素抵抗(n = 28),亚组B——无胰岛素抵抗(n = 22)。所有患者在月经周期的第2至3天进行激素检查。测定抗苗勒管激素、同型半胱氨酸、促卵泡生成素、促黄体生成素(LH)、总睾酮(T)、游离睾酮(FT)、性激素结合球蛋白(SHBG)的血浆水平。在月经周期的第2至3天,所有参与者使用Voluson E10进行超声检查。这样做是为了确定卵巢体积和窦卵泡计数。有RPL的PCOS患者的平均同型半胱氨酸(Hcy)水平(11.5±2.24μmol/l)显著高于对照组(7.55±2.45μmol/l,p<0.001)。有RPL的患者中HHcy和IR的发生率分别为70%和56%,显著高于对照组(HHcy - 54.3%;IR - 9.4%;p<0.0001)。有RPL的患者的HOMA - IR显著高于对照组(p<0.001)。有RPL和有活产史的患者的平均AMH水平无显著差异。在有RPL的PCOS组中,发现Hcy与HOMA - IR、BMI、AMH和FT水平之间存在显著正相关(p<0.001)。有RPL的PCOS患者血清同型半胱氨酸水平升高。这种升高与肥胖程度、BMI、胰岛素抵抗状态、AMH和雄激素水平相关。治疗PCOS女性的高同型半胱氨酸血症和胰岛素抵抗可能成为预防流产和改善生殖结局的基础。